Canandaigua National Corp Regeneron Pharmaceuticals, Inc. Transaction History

Canandaigua National Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 05, 2021	SELL	$446.73 - $548.2 $1.24 Million - $1.52 Million	-2,779 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $5,739 - $7,295	-12 Reduced 0.43%	2,779 $1.34 Million
Q3 2020 Oct 19, 2020	SELL	$544.75 - $658.21 $58,288 - $70,428	-107 Reduced 3.69%	2,791 $1.56 Million
Q2 2020 Jul 07, 2020	BUY	$493.32 - $643.92 $1.43 Million - $1.87 Million	2,898 New	2,898 $1.81 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

Stay updated on Canandaigua National Corp with notifications on news.